Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS30018630HIVENSG00000117385.16protein_codingP3H1NoNo64175Q32P28
TVIS30023450HIVENSG00000117385.16protein_codingP3H1NoNo64175Q32P28
TVIS44005950HTLV-1ENSG00000117385.16protein_codingP3H1NoNo64175Q32P28
TVIS44043811HTLV-1ENSG00000117385.16protein_codingP3H1NoNo64175Q32P28
TCGA Plot Options
Drug Information
GeneP3H1
DrugBank IDDB00126
Drug NameAscorbic acid
Target IDBE0002202
UniProt IDQ32P28
Regulation Typecofactor
PubMed IDs29289682
CitationsOsipyants AI, Poloznikov AA, Smirnova NA, Hushpulian DM, Khristichenko AY, Chubar TA, Zakhariants AA, Ahuja M, Gaisina IN, Thomas B, Brown AM, Gazaryan IG, Tishkov VI: L-ascorbic acid: A true substrate for HIF prolyl hydroxylase? Biochimie. 2018 Apr;147:46-54. doi: 10.1016/j.biochi.2017.12.011. Epub 2017 Dec 28.
GroupsApproved; Nutraceutical
Direct ClassificationButenolides
SMILES[H][C@@]1(OC(=O)C(O)=C1O)[C@@H](O)CO
PathwaysTyrosine Metabolism; Refsum Disease; The Oncogenic Action of Succinate; Disulfiram Action Pathway; Aromatic L-Aminoacid Decarboxylase Deficiency; Oxidation of Branched-Chain Fatty Acids; Catecholamine Biosynthesis; Monoamine Oxidase-A Deficiency (MAO-A); Tyrosinemia, Transient, of the Newborn; Carnitine Synthesis; Phytanic Acid Peroxisomal Oxidation; Hawkinsinuria; Dopamine beta-Hydroxylase Deficiency; Tyrosinemia Type I; Alkaptonuria; Tyrosine Hydroxylase Deficiency; The Oncogenic Action of Fumarate
PharmGKBPA451898
ChEMBLCHEMBL196